The Claim
Thyroid-stimulating receptor antibodies (TRAb) are detectable in some patients with Hashimoto’s thyroiditis who develop hyperthyroidism, but their presence is not sufficient to establish a direct causal role in the transition to hyperthyroidism, as alternative mechanisms such as thyroid tissue destruction or immune modulation may also contribute.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In some people with Hashimoto’s thyroiditis who later develop hyperthyroidism, thyroid-stimulating receptor antibodies can be found in the blood, but their presence alone does not prove they cause the shift to hyperthyroidism, because other biological processes like thyroid damage or changes in immune activity may also be involved.
See the scientific wording
Thyroid-stimulating receptor antibodies (TRAb) can be detected in patients with Hashimoto’s thyroiditis who develop hyperthyroidism, but their presence does not necessarily indicate a direct causal role in the transition, as other factors such as thyroid destruction or immune modulation may contribute.
What the research says
1 studyStudy: Autoimmune Switch of Hashimoto’s thyroiditis to Graves’ Disease: A Rare Case Report
Sometimes, people with Hashimoto’s thyroiditis can suddenly become hyperthyroid because their body starts making antibodies that overstimulate the thyroid — but this is rare, and other things might also cause it.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.